SEB Asset Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
SEB Asset Management's BNTX Position: Q3 2026 in Review
SEB Asset Management reduced its BioNTech (BNTX) stake by 8.2% in Q3 2026, selling an estimated $1.94M and leaving 225,068 shares worth $22.1M. The position accounts for 0.08% of the portfolio, ranked #202.
SEB Asset Management first reported a position in BNTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.8M in Q2 2026. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- SEB Asset Management held 225,068 shares of BioNTech worth $22.1M as of Q3 2026.
- SEB Asset Management sold 20,000 BioNTech shares in Q3 2026, an estimated $1.94M.
- BioNTech made up 0.08% of SEB Asset Management's portfolio in Q3 2026, its #202 holding.
- SEB Asset Management first reported a position in BioNTech in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's BioNTech position peaked at $22.8M in Q2 2026.
- 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.